Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
MindRank, artificial intelligence (AI)-empowered drug discovery company, announced FPI in Phase III Trial of an Oral GLP-1 Receptor Agonist MDR-001.
-
Kneat releases 2025 Annual Shareholder Letter highlighting resilience, opportunities presented by Artificial Intelligence
-
Syntiant Corp.’s CFO Ron Shelton will participate in Bernstein’s 4th Annual Technology, Media and Telecommunications (TMT) Forum.
-
Los Angeles, CA, Feb. 25, 2026 (GLOBE NEWSWIRE) -- Following last week’s rapid appreciation in shares of Algorhythm Holdings (NASDAQ: RIME), Warp issued a statement today cautioning that public...
-
Leadership strategist Amy Summers’ new book Lift offers a practical framework for human-focused mentorship as AI reshapes the modern workplace.
-
SAN FRANCISCO, Feb. 25, 2026 (GLOBE NEWSWIRE) -- Crescendo, the first AI-native contact center, today announced a major evolution of Crescendo AI Insights, which replaces passive dashboards with...
-
Survey of nearly 2,300 recruitment professionals finds AI adoption strongly correlates with revenue growth
-
The Stock Markets are opening with a strong crosscurrent of AI-powered drug discovery, cross-border biologics distribution, and capital structure resets
-
Marking the Group's Strategic Entry into the Region's Rapidly Expanding Consumer Robotics Sector Hong Kong, Feb. 25, 2026 (GLOBE NEWSWIRE) -- Mint Incorporation Limited (“Mint” or the...
-
HealthEdge GuidingCare launches first-of-its-kind Decision Intelligence Ecosystem of leading clinical AI solutions